Comprehensive Skin Toxicity Program for Patients Treated With Epidermal Growth Factor Receptor Inhibitors
This cohort study of 208 patients with cancer treated.
You may also like
A Systematic Analysis for the Global Burden of Disease...
Association of Breast Cancer Irradiation With Cardiac...
Results From the PROSINT Phase 2 Randomized Clinical...
Nonadherence and discontinuation of adjuvant endocrine...
Effect of COVID -19 pandemic on surgical care of...
Surveillance Mammography for Older Patients
About the author
